THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX) (PCX:RPRX) today reported financial results for the three-months and nine-months ended September 30, 2006 and provides patient recruitment update on clinical development programs.
